InsightfulValue
← Home

Bristol Myers Squibb
Bristol Myers Squibb

-12.98%

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Bristol Myers Squibb

πŸ“Š Get full analytics about Bristol Myers Squibb

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Infographic
Infographics
Overview
Bristol Myers Squibb is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments for patients with serious and life-threatening diseases. The company was founded in 1887 and is headquartered in New York City, United States. Bristol Myers Squibb has a strong presence in the United States, with operations and facilities in over 70 countries around the world.
Bristol Myers Squibb is committed to improving patient outcomes by leveraging its scientific expertise and resources to advance the development of new treatments. The company's research and development efforts focus on a variety of therapeutic areas, including oncology, cardiovascular diseases, immunology, and neuroscience.
In addition to its research and development efforts, Bristol Myers Squibb also has a strong commitment to corporate responsibility and sustainability. The company has implemented various initiatives to support access to healthcare in underserved communities, reduce its environmental impact, and promote diversity and inclusion in the workplace.
Bristol Myers Squibb is also dedicated to collaborating with healthcare providers, patient organizations, and other stakeholders to improve patient care and treatment outcomes. The company works closely with these partners to develop educational programs, advocate for policy changes, and support patient advocacy initiatives.
Overall, Bristol Myers Squibb's mission is to use its resources and expertise to create and deliver innovative medicines that help patients live better, healthier lives.
How to explain to a 10 year old kid about the company?
Bristol Myers Squibb

πŸ“ˆ Want to read more about Bristol Myers Squibb?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

QnJpc3RvbC BNeWVycyBT cXVpYmIgaX MgYSBiaWcg Y29tcGFueS B0aGF0IGhl bHBzIHBlb3 BsZSBzdGF5 IGhlYWx0aH kgYnkgbWFr aW5nIG1lZG ljaW5lcy4g VGhleSBmb2 N1cyBtYWlu bHkgb24gdH JlYXRpbmcg c2VyaW91cy BpbGxuZXNz ZXMgbGlrZS BjYW5jZXIs IGhlYXJ0IH Byb2JsZW1z LCBhbmQgb3 RoZXIgdG91 Z2ggZGlzZW FzZXMuIFRo aW5rIG9mIH RoZW0gbGlr ZSBhIHRlYW 0gb2YgaW52 ZW50b3JzIG FuZCBzY2ll bnRpc3RzIH dobyB3b3Jr IHRvZ2V0aG VyIHRvIGZp bmQgbmV3IH dheXMgdG8g aGVscCBwZW 9wbGUgZmVl bCBiZXR0ZX IuPGJyPlRo ZSBjb21wYW 55IG1ha2Vz IG1vbmV5IG J5IHNlbGxp bmcgdGhlIG 1lZGljaW5l cyB0aGV5IG NyZWF0ZS4g V2hlbiB0aG V5IGRpc2Nv dmVyIGEgbm V3IG1lZGlj aW5lIHRoYX Qgd29ya3Mg d2VsbCwgdG hleSBjYW4g c2VsbCBpdC B0byBob3Nw aXRhbHMgYW 5kIHBoYXJt YWNpZXMuIE RvY3RvcnMg Z2l2ZSB0aG VzZSBtZWRp Y2luZXMgdG 8gcGF0aWVu dHMgd2hvIG 5lZWQgdGhl bSwgYW5kIH RoZSBjb21w YW55IGVhcm 5zIG1vbmV5 IGZyb20gZX ZlcnkgbWVk aWNpbmUgc2 9sZC4gU29t ZXRpbWVzIH RoZXkgZXZl biB3b3JrIH dpdGggb3Ro ZXIgY29tcG FuaWVzIHRv IGRldmVsb3 AgbmV3IGRy dWdzLCB3aG ljaCBjYW4g YWxzbyBicm luZyBpbiBt b25leS48Yn I+QnJpc3Rv bCBNeWVycy BTcXVpYmIg aXMgc3VjY2 Vzc2Z1bCBm b3IgYSBmZX cgcmVhc29u cy4gRmlyc3 QsIHRoZXkg aW52ZXN0IG EgbG90IG9m IHRpbWUgYW 5kIG1vbmV5 IGludG8gcm VzZWFyY2gg dG8gZmluZC BuZXcgdHJl YXRtZW50cy 4gVGhpcyBt ZWFucyB0aG V5IGFyZSBv ZnRlbiB0aG UgZmlyc3Qg dG8gZGlzY2 92ZXIgbmV3 IGFuZCBlZm ZlY3RpdmUg bWVkaWNpbm VzLiBTZWNv bmQsIG1hbn kgb2YgdGhl aXIgZHJ1Z3 MgaGVscCB3 aXRoIHZlcn kgc2VyaW91 cyBjb25kaX Rpb25zIHRo YXQgbmVlZC BiZXR0ZXIg dHJlYXRtZW 50cywgc28g dGhlcmUgaX MgYWx3YXlz IGEgaGlnaC BkZW1hbmQg Zm9yIHdoYX QgdGhleSBw cm92aWRlLi A8YnI+TG9v a2luZyBpbn RvIHRoZSBm dXR1cmUsIH RoZXkgd2ls bCBsaWtlbH kgY29udGlu dWUgdG8gYm Ugc3VjY2Vz c2Z1bCBiZW NhdXNlIG5l dyBkaXNlYX NlcyBrZWVw IGFwcGVhcm luZywgYW5k IHBlb3BsZS BhbHdheXMg bmVlZCBiZX R0ZXIgd2F5 cyB0byBzdG F5IGhlYWx0 aHkuIFBsdX MsIHRoZXkg YXJlIGdvb2 QgYXQgd29y a2luZyB3aX RoIG90aGVy IHNjaWVudG lzdHMgYW5k IGNvbXBhbm llcywgd2hp Y2ggY2FuIG hlbHAgdGhl bSBjcmVhdG UgZXZlbiBt b3JlIGhlbH BmdWwgbWVk aWNpbmVzLi BBcyBsb25n IGFzIHRoZX JlIGFyZSBo ZWFsdGggcH JvYmxlbXMg dG8gc29sdm UsIEJyaXN0 b2wgTXllcn MgU3F1aWJi IHdpbGwgaG F2ZSBhIGJp ZyByb2xlIG luIGZpbmRp bmcgc29sdX Rpb25zIGFu ZCBoZWxwaW 5nIHBlb3Bs ZSBsaXZlIG JldHRlciBs aXZlcy48Yn I+
What is special about the company?
Bristol Myers Squibb

πŸ“ˆ Want to read more about Bristol Myers Squibb?

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

MS4gR2xvYm FsIFByZXNl bmNlOiBCcm lzdG9sIE15 ZXJzIFNxdW liYiBvcGVy YXRlcyBpbi Btb3JlIHRo YW4gNjAgY2 91bnRyaWVz IGFuZCBoYX MgYSBzdHJv bmcgZ2xvYm FsIHByZXNl bmNlLiBUaG lzIGFsbG93 cyB0aGUgY2 9tcGFueSB0 byBjYXRlci B0byBhIGRp dmVyc2UgY3 VzdG9tZXIg YmFzZSBhbm QgZXhwYW5k IGludG8gZW 1lcmdpbmcg bWFya2V0cy 48YnI+Mi4g U3Ryb25nIF BvcnRmb2xp bzogVGhlIG NvbXBhbnkg aGFzIGEgZG l2ZXJzaWZp ZWQgcG9ydG ZvbGlvIG9m IHBoYXJtYW NldXRpY2Fs cywgaW5jbH VkaW5nIG1l ZGljaW5lcy Bmb3Igb25j b2xvZ3ksIG ltbXVub2xv Z3ksIGNhcm Rpb3Zhc2N1 bGFyIGRpc2 Vhc2VzLCBh bmQgb3RoZX IgdGhlcmFw ZXV0aWMgYX JlYXMuIEl0 cyBwcm9kdW N0cyBoYXZl IGJlZW4gdX NlZCBieSBt aWxsaW9ucy BvZiBwYXRp ZW50cyB3b3 JsZHdpZGUu PGJyPjMuIE ZvY3VzIG9u IFJlc2Vhcm NoIGFuZCBE ZXZlbG9wbW VudDogQnJp c3RvbCBNeW VycyBTcXVp YmIgaW52ZX N0cyBoZWF2 aWx5IGluIH Jlc2VhcmNo IGFuZCBkZX ZlbG9wbWVu dCwgd2l0aC BhIGZvY3Vz IG9uIGRldm Vsb3Bpbmcg aW5ub3ZhdG l2ZSBtZWRp Y2luZXMgdG 8gYWRkcmVz cyB1bm1ldC BtZWRpY2Fs IG5lZWRzLi BJdCBoYXMg YSByb2J1c3 QgcGlwZWxp bmUgb2YgcG 90ZW50aWFs IHRyZWF0bW VudHMgZm9y IGEgcmFuZ2 Ugb2YgZGlz ZWFzZXMuPG JyPjQuIENv bGxhYm9yYX RpdmUgUGFy dG5lcnNoaX BzOiBUaGUg Y29tcGFueS BoYXMgZm9y bWVkIHN0cm F0ZWdpYyBw YXJ0bmVyc2 hpcHMgd2l0 aCBvdGhlci BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMsIGFjYW RlbWljIGlu c3RpdHV0aW 9ucywgYW5k IHJlc2Vhcm NoIG9yZ2Fu aXphdGlvbn MgdG8gZHJp dmUgaW5ub3 ZhdGlvbiBh bmQgZGV2ZW xvcCBuZXcg dGhlcmFwaW VzLjxicj41 LiBDb21taX RtZW50IHRv IFBhdGllbn QgQWNjZXNz OiBCcmlzdG 9sIE15ZXJz IFNxdWliYi BpcyBjb21t aXR0ZWQgdG 8gaW1wcm92 aW5nIGFjY2 VzcyB0byBo ZWFsdGhjYX JlIGZvciBw YXRpZW50cy Bhcm91bmQg dGhlIHdvcm xkLiBUaGUg Y29tcGFueS BoYXMgdmFy aW91cyBpbm l0aWF0aXZl cywgc3VjaC BhcyBwYXRp ZW50IGFzc2 lzdGFuY2Ug cHJvZ3JhbX MsIHRvIGhl bHAgcGF0aW VudHMgaW4g bmVlZCBhY2 Nlc3MgdGhl aXIgbWVkaW NpbmVzLjxi cj42LiBDb3 Jwb3JhdGUg U29jaWFsIF Jlc3BvbnNp YmlsaXR5Oi BUaGUgY29t cGFueSBpcy Bjb21taXR0 ZWQgdG8gbW FraW5nIGEg cG9zaXRpdm UgaW1wYWN0 IG9uIHNvY2 lldHkgdGhy b3VnaCBpdH MgY29ycG9y YXRlIHNvY2 lhbCByZXNw b25zaWJpbG l0eSBpbml0 aWF0aXZlcy 4gVGhpcyBp bmNsdWRlcy Bpbml0aWF0 aXZlcyByZW xhdGVkIHRv IGVudmlyb2 5tZW50YWwg c3VzdGFpbm FiaWxpdHks IHBhdGllbn QgZWR1Y2F0 aW9uLCBhbm QgY29tbXVu aXR5IG91dH JlYWNoIHBy b2dyYW1zLj xicj43LiBT dHJvbmcgRm luYW5jaWFs IFBlcmZvcm 1hbmNlOiBC cmlzdG9sIE 15ZXJzIFNx dWliYiBoYX MgYSBzdHJv bmcgdHJhY2 sgcmVjb3Jk IG9mIGZpbm FuY2lhbCBw ZXJmb3JtYW 5jZSwgd2l0 aCBjb25zaX N0ZW50IHJl dmVudWUgZ3 Jvd3RoIGFu ZCBhIHN0cm 9uZyBiYWxh bmNlIHNoZW V0LiBUaGlz IHN0YWJpbG l0eSBhbGxv d3MgdGhlIG NvbXBhbnkg dG8gY29udG ludWUgaW52 ZXN0aW5nIG luIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCBhbm QgcHVyc3Vl IHN0cmF0ZW dpYyBvcHBv cnR1bml0aW VzLjxicj44 LiBDdWx0dX JlIG9mIERp dmVyc2l0eS BhbmQgSW5j bHVzaW9uOi BUaGUgY29t cGFueSBoYX MgYSBzdHJv bmcgY3VsdH VyZSBvZiBk aXZlcnNpdH kgYW5kIGlu Y2x1c2lvbi wgd2l0aCBh IHdvcmtmb3 JjZSB0aGF0 IGlzIHJlZm xlY3RpdmUg b2YgdGhlIG dsb2JhbCBj b21tdW5pdG llcyBpdCBz ZXJ2ZXMuIF RoaXMgaGVs cHMgZHJpdm UgY3JlYXRp dml0eSwgaW 5ub3ZhdGlv biwgYW5kIG EgZGVlcCB1 bmRlcnN0YW 5kaW5nIG9m IGRpZmZlcm VudCBwYXRp ZW50IG5lZW RzLjxicj45 LiBTdHJvbm cgTGVhZGVy c2hpcDogQn Jpc3RvbCBN eWVycyBTcX VpYmIgaGFz IGEgaGlnaG x5IGV4cGVy aWVuY2VkIG FuZCBkZWRp Y2F0ZWQgbG VhZGVyc2hp cCB0ZWFtLC B3aXRoIGEg dHJhY2sgcm Vjb3JkIG9m IGRyaXZpbm cgZ3Jvd3Ro IGFuZCBpbm 5vdmF0aW9u LiBUaGlzIH Byb3ZpZGVz IGEgc3Ryb2 5nIGZvdW5k YXRpb24gZm 9yIHRoZSBj b21wYW55J3 Mgc3VjY2Vz cy48YnI+MT AuIFJlY29n bml0aW9uIG FuZCBBd2Fy ZHM6IFRoZS Bjb21wYW55 J3MgZWZmb3 J0cyBpbiBy ZXNlYXJjaC BhbmQgZGV2 ZWxvcG1lbn QsIHBhdGll bnQgYWNjZX NzLCBhbmQg Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eSBoYXZlIG JlZW4gcmVj b2duaXplZC B0aHJvdWdo IHZhcmlvdX MgYXdhcmRz IGFuZCByZW NvZ25pdGlv biwgc3VjaC BhcyBiZWlu ZyByYW5rZW QgYW1vbmcg dGhlIHRvcC AxMDAgQmVz dCBDb3Jwb3 JhdGUgQ2l0 aXplbnMgYn kgQ29ycG9y YXRlIFJlc3 BvbnNpYmls aXR5IE1hZ2 F6aW5lLg==
What the company's business model?
Bristol Myers Squibb

πŸ“ˆ Want to read more about Bristol Myers Squibb?

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

QnJpc3RvbC BNeWVycyBT cXVpYmIgaX MgYSBnbG9i YWwgYmlvcG hhcm1hY2V1 dGljYWwgY2 9tcGFueSB0 aGF0IGZvY3 VzZXMgb24g ZGV2ZWxvcG luZyBhbmQg ZGVsaXZlcm luZyBpbm5v dmF0aXZlIG 1lZGljaW5l cyBmb3IgcG F0aWVudHMg d2l0aCBzZX Jpb3VzIGFu ZCBsaWZlLX RocmVhdGVu aW5nIGRpc2 Vhc2VzLiBU aGVpciBidX NpbmVzcyBt b2RlbCBpcy Bkcml2ZW4g YnkgdGhlaX IgY29tbWl0 bWVudCB0by BkaXNjb3Zl cmluZywgZG V2ZWxvcGlu ZywgYW5kIG RlbGl2ZXJp bmcgbGlmZS 1jaGFuZ2lu ZyB0cmVhdG 1lbnRzIGZv ciBwYXRpZW 50cyBhbmQg Y3JlYXRpbm cgbG9uZy10 ZXJtIHZhbH VlIGZvciB0 aGVpciBzdG FrZWhvbGRl cnMuPGJyPl RoZWlyIG1h aW4gYnVzaW 5lc3Mgc2Vn bWVudHMgaW 5jbHVkZTo8 YnI+MS4gSW 5ub3ZhdGl2 ZSBNZWRpY2 luZXM6IFRo aXMgc2VnbW VudCBmb2N1 c2VzIG9uIG RldmVsb3Bp bmcgYW5kIG NvbW1lcmNp YWxpemluZy BtZWRpY2lu ZXMgaW4gdm FyaW91cyB0 aGVyYXBldX RpYyBhcmVh cyBzdWNoIG FzIG9uY29s b2d5LCBjYX JkaW92YXNj dWxhciwgaW 1tdW5vc2Np ZW5jZSwgYW 5kIGZpYnJv c2lzLjxicj 4yLiBTcGVj aWFsdHkgTW VkaWNpbmVz OiBUaGlzIH NlZ21lbnQg Zm9jdXNlcy BvbiBkZXZl bG9waW5nIG FuZCBjb21t ZXJjaWFsaX ppbmcgbWVk aWNpbmVzIG ZvciByYXJl IGRpc2Vhc2 VzIGFuZCBk aXNvcmRlcn MsIGluY2x1 ZGluZyBoZW 1hdG9sb2d5 LCBpbW11bm 9sb2d5LCBh bmQgbmV1cm 9sb2d5Ljxi cj4zLiBFc3 RhYmxpc2hl ZCBNZWRpY2 luZXM6IFRo aXMgc2VnbW VudCBmb2N1 c2VzIG9uIH Byb3ZpZGlu ZyBwYXRpZW 50cyB3aXRo IGFjY2Vzcy B0byBoaWdo LXF1YWxpdH ksIGVzdGFi bGlzaGVkIG 1lZGljaW5l cyBhdCBhZm ZvcmRhYmxl IHByaWNlcy 48YnI+QnJp c3RvbCBNeW VycyBTcXVp YmIncyBidX NpbmVzcyBt b2RlbCByZW xpZXMgb24g dGhlaXIgYW JpbGl0eSB0 byBkaXNjb3 ZlciBhbmQg ZGV2ZWxvcC Bpbm5vdmF0 aXZlIG1lZG ljaW5lcyB0 aGF0IGFkZH Jlc3Mgc2ln bmlmaWNhbn QgdW5tZXQg bWVkaWNhbC BuZWVkcywg b2J0YWluIH JlZ3VsYXRv cnkgYXBwcm 92YWxzLCBh bmQgc3VjY2 Vzc2Z1bGx5 IGNvbW1lcm NpYWxpemUg dGhlc2UgbW VkaWNpbmVz IGdsb2JhbG x5LiBUaGV5 IGFsc28gaG F2ZSBwYXJ0 bmVyc2hpcH MgYW5kIGNv bGxhYm9yYX Rpb25zIHdp dGggb3RoZX IgYmlvcGhh cm1hY2V1dG ljYWwgY29t cGFuaWVzIH RvIGV4cGFu ZCB0aGVpci Bwb3J0Zm9s aW8gYW5kIH JlYWNoIG5l dyBtYXJrZX RzLjxicj5J biBhZGRpdG lvbiB0byB0 aGVpciBjb3 JlIGJ1c2lu ZXNzLCBCcm lzdG9sIE15 ZXJzIFNxdW liYiBhbHNv IGhhcyBhIH N0cm9uZyBm b2N1cyBvbi BzdXN0YWlu YWJpbGl0eS BhbmQgY29y cG9yYXRlIH Jlc3BvbnNp YmlsaXR5Li BUaGV5IGFp bSB0byBpbX Byb3ZlIGhl YWx0aCBvdX Rjb21lcywg cmVkdWNlIH RoZWlyIGVu dmlyb25tZW 50YWwgaW1w YWN0LCBhbm Qgc3VwcG9y dCB0aGUgY2 9tbXVuaXRp ZXMgd2hlcm UgdGhleSBv cGVyYXRlLj xicj5PdmVy YWxsLCB0aG VpciBidXNp bmVzcyBtb2 RlbCBpcyBj ZW50ZXJlZC Bhcm91bmQg YnJpbmdpbm cgbGlmZS1z YXZpbmcgdH JlYXRtZW50 cyB0byBwYX RpZW50cywg Y3JlYXRpbm cgdmFsdWUg Zm9yIHRoZW lyIHNoYXJl aG9sZGVycy wgYW5kIGNv bnRyaWJ1dG luZyB0byBh IHN1c3RhaW 5hYmxlIGZ1 dHVyZS4=
Is AI a threat?
AI could potentially influence Bristol Myers Squibb (BMS) in several ways, but the extent of the threat depends on various factors.
1. Substitution: AI has the potential to revolutionize drug discovery, development, and personalized medicine. Competitors or new entrants using advanced AI technologies could develop innovative therapies more quickly and at lower costs, potentially substituting BMS products. If AI-enabled companies succeed in creating effective alternatives or worsening the efficacy of existing drugs, this would pose a material threat to BMS’s market share.
2. Disintermediation: While BMS primarily operates in pharmaceuticals, advancements in AI-driven telemedicine and digital health platforms may change the landscape of how patients receive treatments and follow-up care. If such platforms increasingly bypass traditional pharmaceutical channels, BMS could face challenges in maintaining direct relationships with healthcare providers and patients, impacting its ability to effectively market its products.
3. Margin Pressure: The integration of AI in the pharmaceutical industry can lead to more efficient drug development processes, potentially driving down research and development costs. If competitors implement AI successfully and reduce their own costs, BMS may face margin pressure. Increased competition from companies leveraging AI to improve operational efficiencies could also affect pricing power in the market.
In conclusion, while AI presents opportunities for innovation, it also poses potential threats to BMS’s competitive positioning through these avenues. The company would need to proactively adapt to these changes by investing in AI technologies and strategic partnerships to mitigate associated risks.
Sensitivity to interest rates
Bristol Myers Squibb’s (BMS) earnings, cash flow, and valuation are influenced by interest rate changes in several ways.
1. Earnings: Changes in interest rates can affect BMS through several channels. For one, higher interest rates typically increase borrowing costs for companies with outstanding debt. If BMS has significant debt, higher interest expenses could reduce net income. Additionally, if higher rates dampen consumer spending, it could lead to lower demand for healthcare products, ultimately impacting sales and earnings.
2. Cash Flow: Rising interest rates may also affect BMS’s cash flow. Increased borrowing costs would lead to lower net cash flows from financing activities. Furthermore, if consumers and insurers cut back on spending due to higher rates, it could reduce cash inflows from sales. Conversely, if interest rates rise significantly, the company may see an uptick in investment income from cash or investments held.
3. Valuation: The valuation of BMS is closely related to discount rates used in financial models. When interest rates rise, the discount rate applied to future cash flows increases, which can lower the present value of those cash flows. This typically leads to a decrease in stock price, as investors may require a higher return on investment to compensate for increased risk associated with higher rates.
In summary, Bristol Myers Squibb’s earnings, cash flow, and valuation are sensitive to interest rate changes, primarily through the channels of financing costs, consumer behavior, and the discounting of future cash flows. The overall impact will depend on the magnitude of interest rate changes and the company’s financial strategies in response to those changes.
Resilience to the future changes
Bristol Myers Squibb

πŸ“ˆ Want to read more about Bristol Myers Squibb?

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgQn Jpc3RvbCBN eWVycyBTcX VpYmLigJlz IChCTVMpIG Vjb25vbWlj cyBvdmVyIH RoZSBuZXh0 IDPigJM1IH llYXJzIGlz IHRoZSBsb3 NzIG9mIHBh dGVudCBleG NsdXNpdml0 eSBmb3Iga2 V5IGJsb2Nr YnVzdGVyIG RydWdzIGNv bWJpbmVkIH dpdGggdGhl IGZhaWx1cm UgdG8gcmVw bGFjZSBsb3 N0IHJldmVu dWUgdGhyb3 VnaCBuZXcg cHJvZHVjdC BsYXVuY2hl cy4gSW4gcG FydGljdWxh ciwgaWYgQk 1T4oCZcyBs ZWFkaW5nIG 1lZGljYXRp b25zLCBzdW NoIGFzIE9w ZGl2byAobm l2b2x1bWFi KSBvciBFbG lxdWlzIChh cGl4YWJhbi ksIHdlcmUg dG8gZmFjZS BzaWduaWZp Y2FudCBnZW 5lcmljIGNv bXBldGl0aW 9uIHdpdGhv dXQgZWZmZW N0aXZlIG5l dyB0aGVyYX BpZXMgdG8g Y29tcGVuc2 F0ZSwgdGhl IGltcGxpY2 F0aW9ucyBj b3VsZCBiZS BzZXZlcmUu PGJyPkluIH RoaXMgc2Nl bmFyaW8sIH RoZSBmb2xs b3dpbmcgZW Nvbm9taWMg aW1wYWN0cy Bjb3VsZCBt YW5pZmVzdD o8YnI+MS4g PHN0cm9uZz 5NYXJnaW5z PC9zdHJvbm c+OiBCTVMg d291bGQgbG lrZWx5IHNl ZSBhIHNpZ2 5pZmljYW50 IGRlY2xpbm UgaW4gaXRz IGdyb3NzIG FuZCBvcGVy YXRpbmcgbW FyZ2lucy4g Q3VycmVudG x5LCB0aGUg Y29tcGFueS BlbmpveXMg aGlnaCBtYX JnaW5zIGR1 ZSB0byBwcm VtaXVtIHBy aWNpbmcgb2 4gcGF0ZW50 ZWQgZHJ1Z3 MuIEFzIGdl bmVyaWNzIG VudGVyIHRo ZSBtYXJrZX QsIHRoZSBw cmljZXMgb2 YgdGhlc2Ug ZHJ1Z3Mgd2 91bGQgZHJv cCwgYW5kIH dpdGhvdXQg bmV3IGhpZ2 gtbWFyZ2lu IHByb2R1Y3 RzIHRvIHJl cGxhY2UgdG hpcyByZXZl bnVlLCBvdm VyYWxsIHBy b2ZpdGFiaW xpdHkgd291 bGQgZGVjbG luZS4gVGhl IG9wZXJhdG luZyBtYXJn aW4gY291bG Qgc2hyaW5r IGZyb20gaX RzIGhpc3Rv cmljYWwgbG V2ZWxzLCBw b3RlbnRpYW xseSBmYWxs aW5nIGludG 8gdGhlIGxv dy0yMCUgcm FuZ2Ugb3Ig ZXZlbiBiZW xvdywgZGVw ZW5kaW5nIG 9uIHRoZSBj b21wZXRpdG l2ZSBsYW5k c2NhcGUgYW 5kIG1hcmtl dCByZXNwb2 5zZXMuPGJy PjIuIDxzdH Jvbmc+Q2Fz aCBGbG93PC 9zdHJvbmc+ OiBBcyByZX ZlbnVlcyBk ZWNyZWFzZS wgdGhlIGNv bXBhbnnigJ lzIGNhc2gg ZmxvdyBmcm 9tIG9wZXJh dGlvbnMgd2 91bGQgbGlr ZWx5IHN1Zm Zlci4gV2l0 aCB0aGUgbG 9zcyBvZiBi bG9ja2J1c3 RlciByZXZl bnVlLCBCTV Mgd291bGQg aGF2ZSBsZX NzIGNhc2gg YXZhaWxhYm xlIGZvciBy ZWludmVzdG 1lbnQgaW50 byBSJmFtcD tEIG9yIGZv ciByZXR1cm 5pbmcgY2Fw aXRhbCB0by BzaGFyZWhv bGRlcnMuIF RoZSBmcmVl IGNhc2ggZm xvdyBjb3Vs ZCBkaXAgc2 lnbmlmaWNh bnRseSwgcG 90ZW50aWFs bHkgdHVybm luZyBuZWdh dGl2ZSBpZi B0aGUgZGVj bGluZSBpbi ByZXZlbnVl IGlzIHN0ZW VwIGVub3Vn aCBhbmQgaW YgdGhlIGNv bXBhbnkgc3 RydWdnbGVz IHRvIGNvbn Ryb2wgY29z dHMuIFRoaX MgY291bGQg bGVhZCB0by BpbmNyZWFz ZWQgc2NydX RpbnkgZnJv bSBpbnZlc3 RvcnMgYW5k IGFuYWx5c3 RzLjxicj4z LiA8c3Ryb2 5nPkJhbGFu Y2UgU2hlZX Q8L3N0cm9u Zz46IFRoZS BwcmVzc3Vy ZSBvbiBjYX NoIGZsb3cg YW5kIG1hcm dpbnMgd291 bGQgdWx0aW 1hdGVseSBh ZmZlY3QgQk 1T4oCZcyBi YWxhbmNlIH NoZWV0LiBB cyBlYXJuaW 5ncyBkZWNs aW5lLCB0aG UgY29tcGFu eSBtYXkgZm FjZSBjaGFs bGVuZ2VzIG 1haW50YWlu aW5nIGl0cy BjdXJyZW50 IGRlYnQgbG V2ZWxzLCBw YXJ0aWN1bG FybHkgaWYg aXQgaGFzIH Rha2VuIG9u IGRlYnQgdG 8gZmluYW5j ZSBhY3F1aX NpdGlvbnMg b3Igb3RoZX Igc3RyYXRl Z2ljIGluaX RpYXRpdmVz LiBMaXF1aW RpdHkgcmF0 aW9zIHdvdW xkIHdlYWtl biwgYW5kIH doaWxlIHRo ZSBjb21wYW 55IG1pZ2h0 IGluaXRpYW xseSBzdXN0 YWluIGl0cy BjcmVkaXQg cmF0aW5nLC Bwcm9sb25n ZWQgcG9vci BwZXJmb3Jt YW5jZSBjb3 VsZCBsZWFk IHRvIGRvd2 5ncmFkZXMs IGluY3JlYX NpbmcgYm9y cm93aW5nIG Nvc3RzLiBU aGUgZGVidC 10by1lcXVp dHkgcmF0aW 8gbWF5IHJp c2UgaWYgZX F1aXR5IHZh bHVlcyBkcm 9wIGR1ZSB0 byBkaW1pbm lzaGVkIG1h cmtldCBjb2 5maWRlbmNl LCByZXN1bH RpbmcgaW4g YSBsZXNzIG Zhdm9yYWJs ZSBjYXBpdG FsIHN0cnVj dHVyZS48Yn I+SW4gc3Vt bWFyeSwgdG hlIHBlcm1h bmVudCBpbX BhaXJtZW50 IHNjZW5hcm lvIG9mIGxv c2luZyBwYX RlbnQgZXhj bHVzaXZpdH kgd2l0aG91 dCBuZXcgaG lnaC1yZXZl bnVlIHByb2 R1Y3RzIGNv dWxkIHJlc3 VsdCBpbiBy ZWR1Y2VkIG 1hcmdpbnMs IHNpZ25pZm ljYW50bHkg d2Vha2VuZW QgY2FzaCBm bG93LCBhbm QgYSBjb21w cm9taXNlZC BiYWxhbmNl IHNoZWV0IG ZvciBCcmlz dG9sIE15ZX JzIFNxdWli Yi4gVGhpcy B3b3VsZCBj b2xsZWN0aX ZlbHkgY3Jl YXRlIGNoYW xsZW5nZXMg aW4gc3VzdG FpbmluZyBn cm93dGggYW 5kIGNvdWxk IGFsdGVyIH RoZSBjb21w YW554oCZcy BzdHJhdGVn aWMgZGlyZW N0aW9uIGlu IHRoZSBjb2 1wZXRpdGl2 ZSBwaGFybW FjZXV0aWNh bCBsYW5kc2 NhcGUuPGJy Pg==
Interesting facts about the company
Bristol Myers Squibb

πŸ“ˆ Want to read more about Bristol Myers Squibb?

Sign up for free or log in

πŸ’‘ Learn smarter stock picks with "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvc2 xXTmhmN3Yz Q2VjVVo0dm 9pMlAud2Vi cCIgYWx0PS JCcmlzdG9s IE15ZXJzIF NxdWliYiIg dGl0bGU9Ik JyaXN0b2wg TXllcnMgU3 F1aWJiIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTUwIHdp ZHRoPTUwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE JyaXN0b2wg TXllcnMgU3 F1aWJiPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +ZjCBKb2lu IG5vdyB0by BnZXQgPGk+ IlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3MiPC9pPi BhdCBubyBj b3N0CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IAogICAgIC AgIAogICAg ICAgIDxzcG FuIGNsYXNz PSdibHVycm VkLXRleHQn PgogICAgIC AgICAgICBN UzRnUW5KcG MzIFJ2YkNC TmVXVnkgY3 lCVGNYVnBZ bSBJZ2QyRn pJR1p2IGRX NWtaV1FnYV cgNGdNVGc0 TnlCaSBlU0 JYYVd4c2FX IEZ0SUUxal RHRnkgWlc0 Z1FuSnBjMy BSdmJDQmhi bVFnIFNtOW 9iaUJTYVgg QnNaWGtnVF hsbCBjbk1n WVhNZ1lTIE J3YUdGeWJX RmogWlhWMG FXTmhiQyBC amIyMXdZVz U1IElHbHVJ RU5zYVcgNT BiMjRzSUU1 bCBkeUJaYj NKckxqIHhp Y2o0eUxpQl UgYUdVZ1ky OXRjRyBGdW VTQmlaV05o IGJXVWdhMj V2ZDIgNGdZ WE1nUW5KcC BjM1J2YkNC TmVXIFZ5Y3 lCRGIyMXcg WVc1NUlHbH VJRCBFNU1E QWdZVzVrIE lHMWxjbWRs WkMgQjNhWF JvSUUxQiBJ RU5vWlhObF luIEp2ZFdk b0lFMWggYm 5WbVlXTjBk WCBKcGJtY2 dRMjl0IGNH RnVlU0IwYn kgQm1iM0p0 SUVKeSBhWE 4wYjJ3dFRY IGxsY25NZ1 EyOXkgY0c5 eVlYUnBiMi A0Z2FXNGdN VGsxIE9DND hZbkkrTXkg NGdTVzRnTV RrNCBPU3dn UW5KcGMzIF J2YkMxTmVX VnkgY3lCRG IzSndiMyBK aGRHbHZiaU J0IFpYSm5a V1FnZDIgbD BhQ0JUY1hW cCBZbUlnUT I5eWNHIDl5 WVhScGIyNG cgZEc4Z1lt VmpiMiAxbE lIUm9aU0J3 IGNtVnpaVz UwTFcgUmhl U0JDY21sei BkRzlzTFUx NVpYIEp6SU ZOeGRXbGkg WWlCRGIyMX dZVyA1NUxq eGljajQwIE xpQkNjbWx6 ZEcgOXNJRT E1WlhKeiBJ Rk54ZFdsaV lpIEJwY3lC amRYSnkgWl c1MGJIa2dj bSBGdWEyVm tJR0Z6IElH OXVaU0J2Wm kgQjBhR1Vn ZEc5dyBJRE l3SUd4aGNt IGRsYzNRZ2 NHaGggY20x aFkyVjFkRy BsallXd2dZ Mjl0IGNHRn VhV1Z6SUcg bHVJSFJvWl NCMyBiM0pz WkM0OFluIE krTlM0Z1ZH aGwgSUdOdm JYQmhibiBr Z2FHRnpJR0 VnIGMzUnli MjVuSUcgWn ZZM1Z6SUc5 dSBJSEpsYz JWaGNtIE5v SUdGdVpDQm sgWlhabGJH OXdiVyBWdW RDd2dkMmww IGFDQnZkbV Z5SUQgUXNN REF3SUhOai BhV1Z1ZEds emRIIE1nZD I5eWEybHUg WnlCdmJpQj JZWCBKcGIz VnpJR1J5IG RXY2daR2x6 WTIgOTJaWE o1SUdGdSBa Q0JrWlhabG JHIDl3YldW dWRDQncgY2 05cVpXTjBj eSA0OFluSS tOaTRnIFFu SnBjM1J2Yk MgQk5lV1Z5 Y3lCVCBjWF ZwWW1JZ2FH IEZ6SUdFZ1 pHbDIgWlhK elpTQndiMy BKMFptOXNh VzhnIGIyWW daSEoxWjMg TWdjM0JoYm 01cCBibWNn YlhWc2RHIG x3YkdVZ2RH aGwgY21Gd1 pYVjBhVyBN Z1lYSmxZWE 1zIElHbHVZ MngxWkcgbH VaeUJqWVhK ayBhVzkyWV hOamRXIHho Y2l3Z2IyNW ogYjJ4dloz a3NJRyBsdG JYVnViMnh2 IFoza3NJR0 Z1WkMgQnVa WFZ5YjNOai BhV1Z1WTJV dVBHIEp5UG pjdUlGUm8g WlNCamIyMX dZVyA1NUlH aGhjeUJoIE lIQnlaWE5s Ym0gTmxJR2 x1SUc5MiBa WElnTmpBZ1 kyIDkxYm5S eWFXVnogSU dGdVpDQnRZ WCBKclpYUn pJR2wwIGN5 QndjbTlrZF cgTjBjeUJw YmlCdiBkbV Z5SURFMU1D IEJqYjNWdW RISnAgWlhN Z2QyOXliRy BSM2FXUmxM anhpIGNqND RMaUJDY20g bHpkRzlzSU UxNSBaWEp6 SUZOeGRXIG xpWWlCb1lY TWcgWVNCc2 IyNW5JRyBo cGMzUnZjbm tnIGIyWWdZ MjlzYkcgRm liM0poZEds diBiaUJoYm 1RZ2NHIEZ5 ZEc1bGNuTm 8gYVhCeklI ZHBkRyBnZ2 IzUm9aWEln IGNHaGhjbT FoWTIgVjFk R2xqWVd3Zy BZMjl0Y0dG dWFXIFZ6TE NCaFkyRmsg WlcxcFl5Qn BibiBOMGFY UjFkR2x2IG JuTXNJR0Z1 WkMgQnlaWE 5sWVhKaiBh Q0J2Y21kaG JtIGw2WVhS cGIyNXogSU hSdklHRmtk bSBGdVkyVW daSEoxIFp5 QmthWE5qYj MgWmxjbmtn WVc1ayBJR1 JsZG1Wc2Iz IEJ0Wlc1ME xqeGkgY2o0 NUxpQlVhRy BVZ1kyOXRj R0Z1IGVTQm 9ZWE1nWW0g VmxiaUJ5Wl dOdiBaMjVw ZW1Wa0lHIF p2Y2lCcGRI TWcgWldabW IzSjBjeSBC cGJpQnpkWE 4wIFlXbHVZ V0pwYkcgbD BlU0JoYm1R ZyBjbVZ6Y0 c5dWMyIGxp YVd4cGRIa3 MgSUhKaGJt dHBibSBjZ2 IyNGdkR2hs IElFUnZkeU JLYjIgNWxj eUJUZFhOMC BZV2x1WVdK cGJHIGwwZV NCSmJtUmwg ZUNCbWIzSW dNVCBnZ1ky OXVjMlZqIG RYUnBkbVVn ZVcgVmhjbk 11UEdKeSBQ akV3TGlCQ2 NtIGx6ZEc5 c0lFMTUgWl hKeklGTnhk VyBsaVlpQm 9ZWE1nIFlT QnpkSEp2Ym 0gY2dabTlq ZFhNZyBiMj RnWkdsMlpY IEp6YVhSNU lHRnUgWkNC cGJtTnNkWC BOcGIyNHNJ SGRwIGRHZ2 dhVzVwZEcg bGhkR2wyWl hNZyBkRzhn YzNWd2NHID l5ZENCMWJt UmwgY25KbG NISmxjMiBW dWRHVmtJR2 R5IGIzVndj eUJwYmkgQj BhR1VnZDI5 eSBhM0JzWV dObElHIEZ1 WkNCcGJpQj AgYUdVZ1ky OXRiWCBWdW FYUnBaWE1n IGFYUWdjMl Z5ZG0gVnpM anhpY2o0eC BNUzRnVkdo bElHIE52Yl hCaGJua2cg YVhNZ1lXeH pieSBCamIy MXRhWFIwIF pXUWdkRzhn WTIgOXljRz l5WVhSbCBJ SE52WTJsaG JDIEJ5WlhO d2IyNXogYV dKcGJHbDBl UyBCaGJtUW dhR0Z6IElI WmhjbWx2ZF ggTWdhVzVw ZEdsaCBkR2 wyWlhNZ1pt IDlqZFhObF pDQnYgYmlC cGJYQnliMy BacGJtY2dZ V05qIFpYTn pJSFJ2SUcg MWxaR2xqYV c1bCBjeUJo Ym1RZ2FHIF ZoYkhSb1ky RnkgWlNCcG JpQjFibSBS bGNuTmxjbl psIFpDQmpi MjF0ZFcgNX BkR2xsY3k0 OCBZbkkrTV RJdUlFIGx1 SURJd01qQX MgSUVKeWFY TjBiMiB3Z1 RYbGxjbk1n IFUzRjFhV0 ppSUcgRnVi bTkxYm1ObC BaQ0JwZEhN Z1lXIE54ZF dsemFYUnAg YjI0Z2IyWW dZVyA1dmRH aGxjaUJ3IG FHRnliV0Zq WlggVjBhV0 5oYkNCaiBi MjF3WVc1NU xDIEJEWld4 blpXNWwgTE NCbWIzSWdK RCBjMElHSn BiR3hwIGIy NHNJRzFoYT IgbHVaeUJw ZENCdiBibV VnYjJZZ2RH IGhsSUd4aG NtZGwgYzNR Z2JXVnlaMi BWeWN5QnBi aUIwIGFHVW djR2hoY20g MWhZMlYxZE dsaiBZV3dn YVc1a2RYIE 4wY25rdVBH SnkgUGpFek xpQlVhRyBV Z2FHVmhaSE YxIFlYSjBa WEp6SUcgOW 1JRUp5YVhO MCBiMndnVF hsbGNuIE1n VTNGMWFXSm kgSUdseklH eHZZMiBGMF pXUWdhVzRn IFRtVjNJRm x2Y20gc2dR MmwwZVN3Zy BZblYwSUhS b1pTIEJqYj Ixd1lXNTUg SUdGc2MyOG dhRyBGeklI TnBaMjVwIF ptbGpZVzUw SUcgOXdaWE poZEdsdiBi bk1nWVc1a0 lHIFpoWTJs c2FYUnAgWl hNZ2FXNGdi MyBSb1pYSW diRzlqIFlY UnBiMjV6SU cgRnliM1Z1 WkNCMCBhR1 VnZDI5eWJH IFFzSUdsdV kyeDEgWkds dVp5QlFjbS BsdVkyVjBi MjRzIElFNW xkeUJLWlgg SnpaWGtnWV c1ayBJRlJo YlhCaExDIE JHYkc5eWFX UmggSUdsdU lIUm9aUyBC VmJtbDBaV1 FnIFUzUmhk R1Z6TGogeG ljajR4TkM0 ZyBRWE1nYj JZZ01qIEF5 TUN3Z1FuSn AgYzNSdmJD Qk5lVyBWeW N5QlRjWFZw IFltSWdhR0 ZrSUcgRnVJ R1Z0Y0d4di BlV1ZsSUdO dmRXIDUwSU c5bUlHOTIg WlhJZ016QX NNRCBBd0lI QmxiM0JzIF pTQm5iRzlp WVcgeHNlUz Q9CiAgICAg ICAgPC9zcG FuPgogICAg ICAgIAogIC AgICAgIA==
See Company Q&A
Bristol Myers Squibb

πŸ“Š Get full analytics about Bristol Myers Squibb

Sign up for free or log in

πŸ“ Join us and grab your copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal